Monsanto sells BST hormone business
Monsanto will sell its POSILAC bovine somatotropin (BST) business. The company said it would in future concentrate on the profitable genetically modified (GM) crops and crop protection products side of the business.
“While POSILAC is a strong product for the business, we believe repositioning
the business with a strategic owner will allow Monsanto to focus on the growth
of its core seeds and traits business while ensuring that loyal dairy farmers
continue to receive the value of POSILAC in their operations,” said Carl Casale,
Monsanto’s executive vice-president of strategy and operations.
BST is a
controversial hormone and used to boost milk yields in the USA, but is banned in
the EU on human health grounds.
Related website:
Monsanto
